Understand the source comparison
SS-LUP-332 Blood Work Labs: Research vs Clinical Comparison
Baseline CMP + Lipid Panel Required before first dose; fasting 12–14 hours Standard pre-treatment metabolic workup Non-negotiable. No valid study without baseline Liver Enzymes (AST, ALT, GGT) Baseline + Week 4 + Week 8 + endpoint Monitored in hepatotoxic drug
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Baseline CMP + Lipid Panel
- Required before first dose; fasting 12–14 hours
- Standard pre-treatment metabolic workup
- Non-negotiable. No valid study without baseline
- Liver Enzymes (AST, ALT, GGT)
- Baseline + Week 4 + Week 8 + endpoint
- Monitored in hepatotoxic drug trials
- Week 4 interval catches early enzyme elevation
- Fasting Insulin + HOMA-IR
- Baseline + Week 8 + endpoint
- Rarely included in standard panels
- Single best non-invasive insulin resistance marker
- HbA1c
- Baseline + endpoint (≥12-week studies)
- Standard diabetes screening marker
- Useful for long protocols; insensitive <12 weeks
- Thyroid Panel (TSH, fT3, fT4)
- Baseline + endpoint if dose >5mg/kg
- Monitored in thyroid-active compounds
- REV-ERB can alter circadian thyroid signaling